Cash and cash equivalents at 30th June 2023 were approximately $4m, and the Company announced on 11th August 2023 that it had secured a further $6.5m in clean debt.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NMRD:
- Nemaura Medical Secures $6.5m in Non-Dilutive Funding
- Nemaura Medical reports 2023 EPS (57c), consensus (53c)
- Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023
- Nemaura Medical announces next commercialization stage of its proBEAT platform
- NMRD Earnings this Week: How Will it Perform?
